Initiatives for Sustainable Development Goals (SDGs)

The Eisai Group’s Corporate Concept is “to give first thought to patients and the people in the daily living domain, and increase the benefits that healthcare provides to them as well as meet their diversified healthcare needs worldwide.” Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. We believe that our initiatives lead to the achievement of the United Nation’s 17 Sustainable Development Goals (SDGs).

Through the initiatives listed below, Eisai will endeavor to contribute to the achievement of SDGs.

Good Health and Well-Being

  • Creation of innovative medicines

  • Provision of not only medicines, but also solutions

  • Initiatives to eliminate neglected tropical diseases (NTDs) which spread in developing countries

  • Provision of Eisai products based on Affordable Pricing Policy in developing and emerging countries

Lymphatic Filariasis

Delivery of DEC for LF elimination: Provided approx. 400 million to 8 African countries.

Capacity building in local area in Kenya: Installed water tanks in collaboration with NPO & MoH in Kenya and Merck KGaA to supply clean water for Kenya's NTD endemic regions.


Development of new treatment: Conducting clinical study of in-house developed antifungal agent fosravuconazole (E1224)in partnership with the Drugs for Neglected Diseases initiative (DNDi)."

Disease awareness activities in Sudan: Implementing disease awareness activities for residents and surveys for mycetoma patients to facilitate early diagnosis & treatment in partnership with AAR Japan and DNDi.

Clean Water and Sanitation

  • Handling the risk of water shortage through the efficient use of water resources